# Atlas Bio **Source:** https://www.startuphub.ai/startups/atlas-bio **Profile type:** Startup > Developing a foundational AI model to run in silico clinical trials by simulating patient-level efficacy and safety signals before Phase II. ## About Atlas Bio is a Swiss tech-bio firm that has developed a foundational AI model to conduct in silico clinical trials. This technology simulates patient-level efficacy and safety signals prior to Phase II, with the goal of de-risking clinical development, enhancing trial design, and potentially replacing animal studies and traditional Phase II trials. The platform is trained on human transcriptomic data to predict drug responses in virtual patient cohorts. ## Key facts - **Slug:** atlas-bio - **Website:** https://atlas.bio - **Location:** Basel, Switzerland - **Founded:** 2024-01-01 - **Employees:** 1 - **Operating status:** Active - **Total funding:** $10M - **Sectors / tags:** Biotechnology, Pharmaceuticals, Healthcare, Biotech, MedTech - **Social:** - LinkedIn: https://www.linkedin.com/company/atlasbio ## StartupHub.ai scores - **Ahrefs DR:** 4/100 - **Effective DR:** 72/100 - **Agent Readiness:** D (57/100) - **Data Trust:** 54/100 ## Funding rounds | Date | Round | Amount | Lead investors | | --- | --- | --- | --- | | 27 Oct 2026 | [Seed](https://www.startuphub.ai/investment_rounds/atlas-bio-seed-2026) | $10M | [Creandum](https://www.startuphub.ai/investors/creandum) | ## Tech stack Detected on atlas.bio, last scanned 2026-10-27. - **Frontend:** Astro - **CDN:** Cloudflare - **Email provider:** Google Workspace ## JSON-LD Structured data aligned with this page's `